Feasibility Assessment of Implementing a Care System to PREVENT Iatrogenic Dependency (ID)

Aged Clinical Trial

— PREVENT-ID  

Official title:

Feasibility Assessment of Implementing a Care System to PREVENT Iatrogenic Dependency (ID) Related to Hospitalization in People Over 70 Years : Pilot Study. PREVENT-ID

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06173154
• Other study ID #: RC31/21/0171
• Status: Not yet recruiting
• Phase: N/A
• Start date: June 4, 2024
• Est. completion date: December 31, 2024

Study information

• Verified date: April 2024
• Source: University Hospital, Toulouse
• Contact: Caroline BERBON
• Phone: 05 61 77 70 17
• Email: berbon.c[@]chu-toulouse.fr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To assess the feasibility of a care system to prevent iatrogenic dependency during hospitalisation in people 70 years old and over. 2 cares units participate : one with routine care and the other with a care system to prevent ID. The caregivers of this unit receive training about iatrogenic dependency and how prevent it. They set up this prevention and the research compare evolution of dependence hospitalized patients.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 76
• Est. completion date: December 31, 2024
• Est. primary completion date: December 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 70 Years and older

Eligibility

inclusion criteria:

• Patient hospitalized for at least 48 hours in the participating center
• Persons affiliated to a social security system,
• The patient, his trusted person or a relative present during his hospitalization have not expressed opposition to his participation in the research..

exclusion criteria:

• End of life situation,
• ADL at 0/6 for 15 days before hospitalization.
• Refusal to participate,
• Patient under judicial protection

Related Conditions & MeSH terms

• Aged

Intervention

Other:
• Care system to prevent ID
The caregivers of this unit receive training about iatrogenic dependency and how prevent it. They set up this prevention and the research compare evolution of dependence hospitalized patients.
• Routine care
standard care without any specific system in place

Locations

Country	Name	City	State
France	CHU de Toulouse	Toulouse

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Toulouse

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	number of participants with loss of independence	loss of independence is defined as a decrease of at least 0.5 points in Activities of Daily Living (ADL) scale between admission and discharge of the patient within 15 days of admission to the ward, regardless of when this event occurs during the hospitalization.	15 days